Problem Doctors: Is There a System-Level Solution?

  1. Martin T. Donohoe, MD
  1. From Portland State University, Portland, OR 97207-0751.

    TO THE EDITOR:

    The explosive growth of preemployment and random, not-for-cause drug testing in industry and health care raises ethical, legal, and policy questions (1). Such growth has been fueled by popular misconceptions surrounding substance use and abuse, junk science, and business interests (Institute for a Drug-Free Workplace, pharmaceutical firms, and drug-testing companies) and by the public relations campaigns of a multibillion-dollar industry whose entrepreneurial interest lies in magnifying the severity of drug-related problems in the workplace and extolling the benefits of drug testing as a solution (2).

    Preemployment and random drug testing to find one …

    « Previous | Next Article »Table of Contents